Clinical Trial Update: Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating aripiprazole oral solution for Tourette syndrome in children and adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Drugs mentioned

• aripiprazole oral solution (aripiprazole)

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Tourette Syndrome | Phase 3 | Status: COMPLETED